Drug Use, Harmful Use
Conditions
Keywords
DRUG PREVENTION, BINATIONAL, CASUAL USE OF ILLICIT DRUGS, BRIEF INTERVENTION, SBIRT
Brief summary
The goal of the US-Mexico Binational Quit Using Drugs Intervention Trial (QUIT) is a multi-site study conducted in the US (East Los Angeles) and Mexico (Tijuana) which aims to reduce drug demand on both sides of the border. The study also aims to build a collaborative partnership between the US and Mexico research teams. The Bi-National QUIT Study will conduct a randomized control trial for risky drug use in several Los Angeles area community health centers. The intent of the trial is to interrupt the progression to addiction for the casual and occasional users of illicit drugs and non-medical users of pharmaceuticals. The Bi-National QUIT protocol will include (1) a computerized assessment of the patient's drug-use history (2) very brief (\<5 minutes) clinician advice during a patients pre-arranged medical visit which will be preceded by a computerized assessment of the patient's drug-use history (3) a post visit assessment and video doctor (repeating the very brief clinician advice) in the waiting room (4) two post-visit telephone drug-use counseling sessions to be conducted by drug-health educators at approximately 2 and 6 weeks after the start of the intervention. Follow-up assessments will be conducted at 3 months post-randomization. Parallel activities will take place in the U.S./Los Angeles sites and Mexico/Tijuana sites. Data will be shared between both teams. Data analysis will be collaboratively conducted by both teams.
Interventions
BEHAVIORALQuit Using Drugs Intervention Trial
The goal of the Quit Using Drugs Intervention Trial (QUIT) is to conduct a small RCT of a primary care clinic-based very brief intervention protocol for reducing the use of illegal drugs and the occurrences of drug-related harm in low-income, racially-diverse patient populations at two 'safety-net' clinics in Los Angeles. The design will emphasize screening, very brief clinician advice, and telephone drug-use health education to reduce 'at risk' drug use and thus interrupt progression from casual or episodic abuse to dependence.
Sponsors
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
University of California, Los Angeles
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
US Sites: Inclusion Criteria Patients * Adult men and women 18 and older receiving care at the study clinics * Will be living in the LA area for the next three months * Have a phone number at which they can be reached for the next three months * Has a primary care visit for themselves on the date of recruitment and enrollment * Has a primary care visit with a regular clinic provider on the date of recruitment and enrollment * English or Spanish-speaking * Report of drug use in the previous 90 days (i.e., cocaine or amphetamines), and has an ASSIST score between 4 and 26 indicating 'at risk' drug use * Accessible by telephone where they can be contacted over time during the study (to conduct follow-up health education phone calls) * Able (not cognitively impaired) and willing to cooperate with data collection and research procedures, including 2 telephone counseling sessions and 2-week, 6-week, and 3-month follow-up assessments * Planning to be in the Los Angeles area for the next 3 months so they can complete the study period Clinicians • Regular staff primary care clinicians of our study clinics Mexico Sites: Inclusion Criteria Patients * Adult men and women 18 and older receiving care at the study clinics * Will be living in the Tijuana area for the next three months * Have a phone number at which they can be reached for the next three months * Has a primary care visit for themselves on the date of recruitment and enrollment * Has a primary care visit with a regular clinic provider on the date of recruitment and enrollment * Spanish-speaking * Report of drug use in the previous 90 days (i.e., cocaine or amphetamines), and has an ASSIST score between 4 and 26 indicating 'at risk' drug use * Accessible by telephone where they can be contacted over time during the study (to conduct follow-up health education phone calls) * Able (not cognitively impaired) and willing to cooperate with data collection and research procedures, including 2 telephone counseling sessions and 2-week, 6-week, and 3-month follow-up assessments * Planning to be in the Tijuana area for the next 3 months so they can complete the study period Clinicians • Regular staff primary care clinicians of our study clinics
Exclusion criteria
US Sites:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from Baseline Self-reported number of drug-free days at 3 months | Past 30 and 90 days |
Outcome results
None listed